Travere Therapeutics
Price & Volume
Stats
See moreOpen | $51.84 |
Previous Close | $52.12 |
Day Range | $51.81-$53.24 |
52W Range | $22.59-$68.73 |
Market Cap | $4.9B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $591.3M |
Revenue Growth (YoY) | 48.2% |
Gross Profit (12 Mos) | $350.1M |
Diluted EPS | -$0.75 |
News
See moreYahoo Finance • last month
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Yahoo Finance • 2 months ago
Travere signals potential for more than $3B in peak annual FILSPARI sales as FSGS launch exceeds expectations
Yahoo Finance • 3 months ago
This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026
About
CEO | Dr. Eric M. Dube Ph.D. |
Address | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 497 |